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Background: Perineural invasion (PNI) is correlated with adverse survival in several malignancies, but its significance
in esophageal squamous cell carcinoma (ESCC) remains to be clearly defined. The objective of this study was to
determine the association between PNI status and clinical outcomes.
Methods: We retrospectively evaluated the PNI of 433 patients with ESCC treated with surgery between 2000
and 2007 at a single academic center. The resulting data were analyzed using Spearman’s rank correlation, the
Kaplan-Meier method, Cox proportional hazards regression modeling and Harrell’s concordance index (C-index).
Results: PNI was identified in 209 of the 433 (47.7%) cases of ESCC. The correlation analysis demonstrated that PNI
in ESCC was significantly correlated with tumor differentiation, infiltration depth, pN classification and stage (P < 0.05).
The five-year overall survival rate was 0.570 for PNI-negative tumors versus 0.326 for PNI-positive tumors. Patients with
PNI-negative tumors exhibited a 1.7-fold increase in five-year recurrence-free survival compared with patients with
PNI-positive tumors (0.531 v 0.305, respectively; P < 0.0001). In the subset of patients with node-negative disease, PNI
was evaluated as a prognostic predictor as well (P < 0.05). In the multivariate analysis, PNI was an independent
prognostic factor for overall survival (P = 0.027). The C-index estimate for the combined model (PNI, gender and
pN status) was a significant improvement on the C-index estimate of the clinicopathologic model alone (0.739 v 0.706,
respectively).
Conclusions: PNI can function as an independent prognostic factor of outcomes in ESCC patients, and the PNI status
in primary ESCC specimens should be considered for therapy stratification.
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Esophageal cancer is one of the most aggressive cancers
worldwide, and its incidence rate has increased signifi-
cantly in recent years [1,2]. As the dominant type of
esophageal cancer in China, esophageal squamous cell
carcinoma (ESCC) has a generally poor prognosis due
to the lack of effective clinical methods for its early
detection. Recently, improvements in diagnostic modal-
ities and the development of a combination treatment* Correspondence: caimuyan@hotmail.com
†Equal contributors
1Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in
South China; Collaborative Innovation Center for Cancer Medicine,
Guangzhou, China
2Department of Pathology, Sun Yat-sen University Cancer Center, No. 651,
Dongfeng Road East, Guangzhou 510060, China
Full list of author information is available at the end of the article
© 2014 Chen et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.of surgery, radiation and chemotherapy have improved the
outcomes for this cancer [3]. Despite these advances, the
prognosis in patients with ESCC remains poor, with an
overall 5-year survival of 15-34% [4,5]. Given the poor
prognosis of ESCC and its high incidence, it is increasingly
important to understand the initiation and progression of
ESCC and to identify the prognostic factors most associ-
ated with it.
An appropriate risk-stratified selection for adjuvant
treatment trials is paramount, considering the high cost
and toxic side effects of chemotherapeutic drugs. A variety
of prognostic characteristics, including tumor location,
size, differentiation, infiltration depth, lymph node in-
volvement and distant metastasis, have been proposed
as relevant factors for predicting the outcomes of
patients with ESCC [6]. These characteristics have beentd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Correlation of perineural invasion with patients’
clinicopathological features in primary esophageal
squamous cell carcinomas
Variables Perineural invasion
Cases Absent Present P value*
Age (years) 0.083
≤ 57.0† 230 110 (47.8%) 120 (52.2%)
> 57.0 203 114 (56.2%) 89 (43.8%)
Gender 0.502
Female 112 61 (54.5%) 51 (45.5%)
Male 321 163 (50.8%) 158 (49.2%)
Location 0.098
Upper 28 14 (50.0%) 14 (50.0%)
Middle 298 145 (48.7%) 153 (51.3%)
Lower 107 65 (60.7%) 42 (39.3%)
Tumor size (cm) 0.952
≤ 4‡ 277 143 (51.6%) 134 (48.4%)
> 4 156 81 (51.9%) 75 (48.1%)
Differentiation 0.017
Well 67 41 (61.2%) 26 (38.8%)
Moderate 288 153 (53.1%) 135 (46.9%)
Poor 78 30 (38.5%) 48 (61.5%)
pT status 0.036
T1 20 15 (75.0%) 5 (25.0%)
T2 104 59 (56.7%) 45 (43.3%)
T3 309 150 (48.5%) 159 (51.5%)
pN status < 0.0001
N0 233 137 (58.8%) 96 (41.2%)
N1 111 59 (53.2%) 52 (46.8%)
N2 71 25 (35.2%) 46 (64.8%)
N3 18 3 (16.7%) 15 (83.3%)
Stage < 0.0001
I 25 19 (76.0%) 6 (24.0%)
II 238 138 (58.0%) 100 (42.0%)
III 170 67 (39.4%) 103 (60.6%)
*Chi-square test; †Median age; ‡Median size.
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signed to predict patients’ survival [7]. Although the
currently proposed TNM system shows conformable
prognostic accuracy, a demand remains for increasing the
accuracy of the existing system for predicting outcomes.
Perineural invasion (PNI) involves cancer cells sur-
rounding nerve fibers and entering the perineurium,
spreading local infiltration and metastasis [8]. Cancer
cells found in the perineurium are indicative of neural
invasion [9]. PNI is regarded as a prominent character-
istic of ESCC, as PNI is frequently observed in ESCC
[10]. The PNI status has been found to be significantly
correlated with poor survival in ESCC patients, as
evidenced by univariate analysis [11]. However, Ochiai
et al. reported that PNI was not a significant prognostic
parameter in esophageal cancer [12]. Moreover, PNI in N0
esophageal cancer was found to have no association with
cancer-specific survival following curative esophagectomy
in a univariate statistical analysis [13]. Although PNI
has been investigated in both esophageal SCC and
adenocarcinoma, its incidence and prognostic value
based on ESCC in high prevalence in a region, with a
focus on PNI, has not been clarified. To address these
issues, we employed a large cohort of patients with
ESCC in a region in where it has a high prevalence to




A total of 433 patients with ESCC who underwent cura-
tive esophagectomies between October 2000 and May
2007 were randomly selected from the Department
of Pathology of Sun Yat-sen University Cancer Center
(Guangzhou, China). The selective criteria included (1)
no adjuvant treatment before the surgery; (2) a complete
resection of the tumor; (3) a negative incised margin;
(4) no distant metastasis; and (5) detailed and complete
follow-up data.
We collected clinicopathologic data that included the
patient’s age, gender, tumor location, tumor size, differ-
entiation, TNM stage, infiltration depth, lymph node
status, vascular invasion and recurrence. These data are
detailed in Table 1. Tumor differentiation was deter-
mined based on the criteria proposed by the WHO’s
classification of Tumours of the Digestive System (2010
version). The tumor stage was defined according to
the American Joint Committee on Cancer/International
Union Against Cancer TNM (tumor-node-metastasis)
classification system (2010 version). The patients were
followed every 3 months for the first year and then
every 6 months for the next 2 years and then annually
after surgery. Tumor recurrences (including local recur-
rence or metastasis) were detected by ultrasonography,CT or MRI. The time of the detection of recurrence was
unknown until the patient died from ESCC, and the
time to death was used instead. The Institute Research
Medical Ethics Committee of Sun Yat-sen University
Cancer Center granted approval for this study.
Pathological evaluation
The patients’ records and original histopathologic slides
were independently reviewed by 2 pathologists with ex-
pertise in gastrointestinal pathology (S.-Y. Xi and M.-Y.
Cai) who were blinded to the pathological diagnoses
and outcome data. Discrepancies were resolved by the
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thologists with a double-headed microscope. The pres-
ence of PNI was carefully evaluated on hematoxylin and
eosin (H&E)-stained slides. The cases were examined
for the presence or absence of PNI, which was defined
as the presence of viable tumor cells in the perineural
space [14]. Descriptions of PNI have included cancer
cells within any layer of the peripheral nerve sheath,
from the abutment of cancer cells with the perineurium
to small clusters of cancer cells within the nerves [15].
When tumor cells are not located inside of the nerve
sheath but are in close proximity to the nerve in the
perineural environment, at least 33% of the circumfer-
ence of the nerve should be surrounded by tumor cells
to diagnose PNI; anything less than 33% represents focal
abutment and not invasion [15].
Statistical analysis
The correlation between PNI and the clinicopathologic
variables of the ESCC patients was evaluated by a χ2-
test. For the univariate analysis, survival curves were
obtained with the Kaplan-Meier method, and the dif-
ferences between the groups in survival were determined
by the log-rank test. Multivariate survival analyses
were performed with the Cox proportional hazard re-
gression model. Harrell’s concordance index (C-index)
was employed to assess the model’s prognostic accuracyFigure 1 The status of perineural invasion (PNI) in ESCC specimens. T
and epineurium (C) of the peripheral nerve sheath are clear examples of P
in close proximity to the nerve in the perineural environment, at least 33%
cells to diagnose PNI (D); anything less than 33% represents focal abutmen
the nerve in the perineural environment (F), it represents negative findingin the multivariate analysis. A P value from a two-tailed
test that was less than 0.05 was considered to be statisti-
cally significant. The statistical analysis was performed
with the SPSS statistical software package (SPSS Stand-




The characteristics and pathological features of our
ESCC cohort’s patients are detailed in Table 1. The
cohort included 321 (74.1%) males and 112 (25.9%) fe-
males, with a mean age at the time of resection of 57.2 years
(range, 30–81). The median follow-up of all patients was
39.0 months, ranging from 1.0 months to 115.0 months.
Sixty-nine percent of the tumors (298 of 433) occurred in
the middle segment of the chest, and the remaining tumors
occurred in the upper (6.5%) and lower (24.7%) segments
of the chest.
Relationship between PNI and clinicopathologic features
in ESCC
PNI was defined as tumor cells within any layer of the
peripheral nerve sheath or tumor cells in the perineural
space that involved at least 33% of the nerve circum-
ference. The patterns of PNI in ESCC specimens were
shown in Figure 1. PNI was identified in 209 (47.7%) ofumor cells located within any of the endoneurium (A), perineurium (B)
NI. When tumor cells are not located inside of the nerve sheath but are
of the circumference of the nerve should be surrounded by tumor
t and not invasion (E). When tumor cells are not in close proximity to
(hematoxylin-eosin staining, ×100).
Table 2 Univariate analysis of perineural invasion and
clinicopathologic variables in patients with primary
esophageal squamous cell carcinoma (log-rank test)






≤ 57.0† 230 62.5 42.0
> 57.0 203 60.1 58.0
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strated that the presence of PNI was significantly corre-
lated with tumor differentiation, infiltration depth, pN
classification and ESCC stage (P < 0.05, Table 1). There
was no significant association between the presence of
PNI and other clinicopathologic features, such as the
patient’s age, gender and location and size of the tumor
(P > 0.05, Table 1).Gender 0.016
Female 112 72.6 NR
Male 321 57.7 41.0
Location 0.083
Upper 28 68.5 79.0
Middle 298 56.2 41.0
Lower 107 70.7 63.0
Tumor size (cm) 0.076
≤ 4‡ 277 66.1 63.0
> 4 156 54.3 38.0
Differentiation 0.021
Well 67 61.9 64.0
Moderate 288 65.5 64.0
Poor 78 44.4 26.0
pT status 0.002
T1 20 58.2 NR
T2 104 71.2 74.0
T3 309 57.9 38.0
pN status < 0.0001
N0 233 79.3 NR
N1 111 48.2 40.0
N2 71 27.4 16.0
N3 18 19.1 11.0
Stage < 0.0001Role of PNI as prognostic factor of outcome in ESCC
patients
The prognostic significance of PNI as well as other
clinicopathologic variables was investigated by univari-
ate analyses. The PNI status (P < 0.0001), patient gender
(P = 0.016), tumor differentiation (P = 0.021), pT status
(P = 0.002), pN status (P < 0.0001) and tumor stage (P <
0.0001) influenced the patients’ overall survival (Table 2).
Patient age and the size and location of the tumor did not
significantly affect outcomes. The 5-year overall survival
rate was greater for patients with PNI-negative tumors
than for patients with PNI-positive tumors (0.570 v 0.326,
respectively; P < 0.0001; Figure 2A). Similar results were
found for recurrence-free survival. Patients with PNI-
negative tumors exhibited a 1.7-fold increase in five-year
recurrence-free survival compared with patients with PNI-
positive tumors (0.531 v 0.305, respectively; P < 0.0001;
Figure 2B).
Among the node-negative patients (233 of 433 pa-
tients, 53.8%), PNI remained a significant predictor of
poor outcomes. The 5-year overall survival rate was more
than 1.4-fold greater among patients with PNI-negative
tumors than among patients with PNI-positive tumors
(0.716 v 0.486, respectively; P < 0.0001; Figure 3A). The
recurrence-free survival at 5 years was 0.682 in patients
with PNI-negative tumors compared with 0.475 in pa-
tients with PNI-positive tumors (P = 0.002; Figure 3B).I 25 67.6 NR
II 238 76.4 NR
III 170 34.9 22.0
Perineural invasion < 0.0001
Absent 224 71.4 79.0
Present 209 47.7 27.0
†Median age; ‡Median size; NR indicates not reached.PNI status is an independent prognostic factor of
outcome in ESCC patients
A Cox multiple regression model was utilized to assess
the influence of all significant covariates on overall sur-
vival in ESCC patients who underwent curative resections.
After controlling for patient gender, tumor differentiation,
pT status, pN status and stage, the multivariate analysis
confirmed that the presence of PNI was a significant inde-
pendent prognostic factor for poor overall survival (hazard
ratio, 1.374; 95% CI, 1.037-1.820; P = 0.027; Table 3). Of
the other parameters, patient gender and pN status were
evaluated as independent prognostic factors for the overall
survival of ESCC patients (P < 0.05; Table 3). Applying
Harrell’s C-index to test the predictive ability of integrat-
ing PNI into the prognostic model in ESCC patients, our
results showed that the PNI status improved the predictiveability when compared with the clinicopathologic model
(C-indexes of 0.739 v 0.706, respectively).
Discussion
PNI is the process of neoplastic invasion of the nerves,
and it is also an important pathway by which tumor’s
progress and spread to the adjacent tissues or organs. It
is commonly detected in human cancers of the pancreas
Figure 2 The association between perineural invasion and ESCC patients’ survival (log-rank test). Kaplan-Meier survival analysis of perineu-
ral invasion for overall survival (A) and recurrence-free survival (B) in ESCC patients.
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cial route for the local spread of tumors that are associ-
ated with poor outcomes in various types of human
cancers. However, the role of PNI status in ESCC and its
utility to clinicians continue to be debated. In our study,
we assessed a retrospective collection of data to determine
the prognostic value of PNI for the survival of patients
with ESCC who underwent curative esophagectomies.
Moreover, our particular interest is in determining the
potential effects of PNI in node-negative ESCC patients.
Our results demonstrated that the presence of PNI
was observed in 47.7% of patients with ESCC as evalu-
ated on H&E-stained slides. However, less than 30% of
the PNI-positive tumors were detected in esophageal
cancer (including SCC and adenocarcinoma) in previous
studies [10,12]. Differences in the histological types and
PNI definitions may contribute to this discrepancy. In the
current study, we utilized a broader definition inclusive
of both of the circumstances: cancer cells surrounding at
least one-third of the nerve without invading through the
nerve sheath, as well as tumor cells within any of the 3
layers of the nerve sheath [19-22]. Furthermore, the in-
creased detection rate observed in our study is most likely
because the pathologic analysis was performed by patholo-
gists with expertise in PNI who were blinded to the
follow-up data in this study. Consistent with our study,
PNI has been recognized in many series as a prevalent
pathological characteristic of gastric cancer and is re-
ported in up to 73% of this tumor at the time of resec-
tion [23]. PNI rates were much higher in pancreatic
cancer (70-100%) and in biliary tract cancer (75-85%)
[16,24]. Our findings suggest that PNI is a common patho-
logic feature of ESCCs removed by radical esophagectomy.
A further correlation analysis revealed that the pres-
ence of PNI in ESCCs was significantly associated with
tumor differentiation, infiltrate depth, pN status andstage. Studies in other cancers have led to similar con-
clusions. For instance, Ochiai et al. reported that the
presence of PNI in esophageal cancer was closely corre-
lated with the depth of invasion [12]. Liebig et al. found
that PNI was associated with a more advanced stage and
poor tumor differentiation in colorectal cancer [20]. Pre-
vious studies also showed that evidence of PNI on a
prostate needle biopsy is predictive of a higher T stage
and extracapsular invasion at resection [25,26]. Further-
more, the presence of PNI was found to be correlated
with tumor size, margin status, lymph node metastasis
and AJCC stage in patients with pancreatic ductal adeno-
carcinoma [14]. Taken together, these data suggest that
PNI plays an important role in the development and/or
progression of human cancers.
Our findings of the PNI status and its correlation with
ESCC patients’ outcomes are consistent with the results of
other groups. In 1999, Torres et al. showed a significant
association between the presence of PNI and the poor
survival of patients with ESCC as evidenced by a univar-
iate analysis [11]. Other groups have reported similar
results [27-29], in which PNI was a significant pathologic
parameter in head and neck cancers, heralding decreased
survival, increased locoregional recurrence rates and a
shorter time to relapse. In a more recent study, Liegig
et al. suggested that PNI is correlated with decreased sur-
vival on a multivariate analysis and established that PNI is
an independent predictor of outcomes in colorectal cancer
patients [20]. Importantly, PNI in pT3N0 rectal cancer is
also found to be an independent risk predictor of a local
recurrence [30]. Notably, other published reports show
no significant prognostic value for PNI to predict
the outcomes in patients with esophageal squamous
cell carcinoma and adenocarcinoma [12,13]. Taken
together, differences in the clinicopathologic characteris-
tics among cohorts, geographic backgrounds, definition
Figure 3 Univariate survival analysis with regard to perineural invasion in the subset of ESCC patients with node-negative disease. The
presence of perineural invasion was identified as a prognostic predictor of overall survival (A) and recurrence-free survival (B) in ESCC patients
with node-negative disease.
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different definitions of end points (disease-free, cancer
specific or overall survival) may contribute to the con-
troversial results. In our study, the findings of a signifi-
cant association between the PNI status and clinical
outcome in esophageal cancer may be strengthened by
the single histological type and large sample size.
Generally, our results support the idea that the pres-
ence of PNI may improve the ability to discriminate
among ESCC patients’ outcomes, especially for patients
who are node-negative. It is well known that the pTNM
stage and tumor differentiation are the best-established
risk predictors for important aspects affecting the out-
comes of patients with ESCC. These two variables, based
on specific clinicopathologic features and the extent of
the disease, may have reached their limits in providing
critical information influencing patient prognosis and
treatment strategies at the pN0 stage. Moreover, the
outcomes of patients with the same stages following
surgery are substantially different, and such large dis-
crepancies have not been well understood [31,32]. Thus,
there is a need for new objective strategies that canTable 3 Cox multivariate analyses of prognostic factors
for overall survival
Variables Hazard ratio 95% CI P value
Gender (female v male) 1.379 1.005-1.891 0.046
Differentiation
(well v moderate v poor)
1.116 0.897-1.389 0.324
pT status ( T1 v T2 v T3) 1.146 0.831-1.579 0.406
pN status (N0 v N1 v N2 v N3) 1.687 1.339-2.125 < 0.0001




CI, confidence interval.more effectively distinguish between patients with fa-
vorable and unfavorable outcomes. In the present study,
our data support the concept that PNI, as detected by
H&E staining, can identify ESCC patients with or with-
out an aggressive clinical course and/or poor outcome
at the pN0 stage. Thus, the evaluation of PNI may be-
come a factor for predicting the prognosis and render-
ing a more tailored treatment strategy in patients with
ESCC.
The retrospective nature of this study may be consid-
ered its major limitation, and it may have influenced
these results. However, the study was strengthened by
the fact that all of the histopathological slides were
re-evaluated by the same gastrointestinal pathologists.
Although our findings should be confirmed by pro-
spective studies, we believe that our results contribute
to the literature because it includes only patients with
ESCC. To our knowledge, this is the first report to in-
vestigate the prognostic ability of PNI in an area of high
ESCC prevalence; however, further external validation
of our findings using pooled multicenter data is
needed.
Conclusions
In conclusion, the presence of PNI was a strong and in-
dependent predictor of a poor outcome, as indicated by
the univariate and multivariate analyses. Adding the
PNI model could improve the ability to discriminate
ESCC patients’ outcomes. Our data suggest that PNI
could function as an independent prognostic factor of
outcomes in ESCC and support the consideration of the
PNI status in primary ESCC specimens for therapy
stratification. In particular, we advocate for the consid-
eration of node-negative ESCC patients who are PNI
positive for treatment with the effective adjuvant ther-
apies that are currently available.
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